Sensing for effective endovascular procedures

The Company

Medyria is a Swiss medtech startup that engineers technologies for

endovascular catheter navigation and sensing.

In 2013, Dr. Mauro Sette came with the idea of incubating a project on the tracking of catheters. In 2014, Medyria AG was effectively incorporated and funded. Three years later, in 2017, Medyria AG has successfully developed an innovative and proprietary blood flow velocity measuring catheter.

The TrackCath System is designed to support cannulation during Endovascular Aneurysm Repair procedures.


Medyria AG is located in Technopark, Winterthur, Switzerland.

Our goal is to develop devices that enable safer and more effective endovascular procedures.

We develop a unique guiding and sensing medical device based on  proprietary Blood Flow Velocity Sensor technology. 


The TrackCath System is designed to be cost-effective and safe during EVAR procedures.


Our team

Valerie Dubois

Quality and regulatory

Gilles Lachkar


Dr. Mauro M. Sette

CTO & Founder

Anita Di Iasio


Jarmo Hytönen


Lukas Ruckstuhl

Production Process Engineer

Premathilaka Himidunge

Production Technician

Mirjana Seidovic 

Production Technician

Maria Maluszynska-Hoffman


Board of directors

Eric le Royer

Gianluigi Berini

Giovanni Leo

Marc Bär

Mauro M. Sette



Medyria AG
c/o Technopark

Technoparkstrasse 2c
8406 Winterthur

mail :

tel :  +41 (0) 52 214 82 82

fax : +41 (0) 52 508 50 65


CAUTION - Investigational device. Limited by law to investigational use.